abstract |
In the present invention, a hybrid polypeptide that specifically binds to a disease-related isoform of a polypeptide involved in a disease of protein aggregation is provided. Hybrid polypeptides can be used for diagnosis and treatment of such diseases. In certain embodiments, a hybrid protein is provided that specifically binds to an infectious form of prion (PrP Sc ). |